首页|自体动静脉内瘘与带隧道带涤纶套导管血管通路对MHD患者的临床效果观察

自体动静脉内瘘与带隧道带涤纶套导管血管通路对MHD患者的临床效果观察

扫码查看
目的 探讨自体动静脉内瘘(autogenous arteriovenous fistulas,AVF)与带隧道带涤纶套导管(tunneled cuffed catheter,TCC)血管通路在维持性血液透析(maintenance hemodialysis,MHD)患者的临床效果.方法 选取2022年1月至2023年6月于解放军火箭军特色医学中心应用AVF行MHD的66例患者(AVF组),另根据性别、年龄以1∶1的比例选取同期应用TCC行MHD的66例患者(TCC组).治疗6个月后,比较透析前后两组患者的肾功能如SCr、BUN和β2微球蛋白(β2-microglobulin,β2-MG)水平,PLT活化指标如血小板α颗粒膜糖蛋白(CD62P)、溶酶体相关膜蛋白3(CD63)、GPⅡb/Ⅲ纤维蛋白原受体(PAC-1)水平及骨硬化蛋白(sclerostin)、D-二聚体(D-dimer,DD)、Dickkopf相关蛋白1(DKK-1)的水平和并发症发生情况.结果 132例患者中男85例、女47例;年龄41~76岁,平均(57.0±7.5)岁;两组透析年龄、透析时长、原发病等资料的比较,差异无统计学意义(P>0.05).治疗6个月后,AVF组与TCC组SCr、BUN、β2-MG水平均较治疗前降低,但两组SCr、BUN、β2-MG水平的比较,差异无显著意义(P>0.05);AVF组与TCC组CD62P、CD63、PAC-1、Sclerostin、D-D、DKK-1的水平均较治疗前升高,且AVF组各指标水平均低于TCC组,差异有统计学意义(P<0.05).治疗6个月后,AVF组并发症发生率低于TCC组(10.61%比22.73%),差异有统计学意义(P<0.05).结论 AVF与TCC血管通路应用于MHD的效果相当,但AVF血管通路对MHD患者血小板活化及血管钙化的影响较小,临床可首选AVF血管通路方式应用于MHD.
Clinical effect observation on autologous arteriovenous fistula and tunneled cuffed catheter vascular pathways in patients undergoing maintenance hemodialysis
Objective To explore the clinical effect of autologous arteriovenous fistula(AVF)and tunneled cuffed catheter(TCC)vascular pathways in patients undergoing maintenance hemodialysis(MHD).Methods A total of 66 patients undergoing MHD with AVF(AVF group)in PLA Rocket Force Characteristic Medical Center from January 2022 and June 2023 were selected,another 66 patients who underwent MHD with TCC(TCC group)in the same period were selected according to the gender and age.The levels of renal function such as SCr,BUN and β2-microglobulin(β2-MG),PLT activation indicators including PLT α granule membrane glycoprotein(CD62P),lysosomal associated membrane protein 3(CD63),GPⅡb/Ⅲa fibrinogen receptor(PAC-1),and osteoprotegerin(sclerostin),D-dimer(D-D),Dickkopf associated protein 1(DKK-1)and incidence of complications were compared between the two groups before and after six months of treatment.Results Among the 132 patients,85 were males,47 were females,aged from 41 to 76 years,with an average age of(57.0±7.5)years.There were no significant differences in dialysis age,dialysis duration,primary disease,etc.between the two groups(P>0.05).After six months of MHD,the levels of SCr,BUN and β2-MG were decreased in both groups,and there were no significant differences between the two groups(P>0.05).After six months of MHD,the levels of CD62P,CD63,PAC-1,Sclerostin,D-D and DKK-1 were increased in both groups,and the levels of the indicators were lower in AVF group than those in TCC group,with statistical significance(P<0.05).During MHD,the incidence of complications in AVF group was lower than those in TCC group(10.61%vs.22.73%),and the differrences were statistically significant(P<0.05).Conclusions AVF and TCC vascular pathways have the same effect in patients undergoing MHD,however,AVF vascular pathway has fewer effects on PLT activation and vascular calcification after MHD,which can be applied as the first choice for MHD in clinical practice.

maintenance hemodialysis(MHD)vascular pathwayautogenous arteriovenous fistula(AVF)tunneled cuffed catheter(TCC)

王欢、涂晓文、郭俊、槐鹏宇

展开 >

100088 北京,解放军火箭军特色医学中心肾脏病科

维持性血液透析 血管通路 自体动静脉内瘘 带隧道带涤纶套导管

2024

北京医学
中华医学会北京分会

北京医学

CSTPCD
影响因子:0.714
ISSN:0253-9713
年,卷(期):2024.46(11)